Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 19,400 KRW
Change Today +600.00 / 3.19%
Volume 194.2K
As of 2:11 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daewon pharmaceutical co ltd (003220)

Daewon Pharmaceutical Co. Ltd. uses little or no debt in its capital structure and may have less financial risk than the industry aggregate. Accounts Receivable are typical for the industry, with 54.01 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 124.05 days.
View Balance Sheet In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31
Dec 31
Dec 31
Dec 31
4 Year
Cash and Equivalents17,610.624,015.919,030.221,272.9
Short-Term Investments----7,806.26,542.5
TOTAL CASH AND SHORT TERM INVESTMENTS17,610.624,015.926,836.427,815.4
Accounts Receivable31,713.529,258.027,894.225,965.5
Notes Receivable597.0499.167.650.9
Other Receivables3,281.52,679.44,429.35,458.7
TOTAL RECEIVABLES35,592.032,436.532,391.131,475.1
Prepaid Expenses148.185.095.7133.0
Other Current Assets20.277.9232.1449.6
TOTAL CURRENT ASSETS68,401.675,355.483,640.092,242.7
Gross Property Plant and Equipment76,614.179,930.589,434.3104,012.4
Accumulated Depreciation-19,621.4-22,564.0-25,506.7-27,856.0
NET PROPERTY PLANT AND EQUIPMENT56,992.757,366.563,927.676,156.4
Long-Term Investments2,118.81,997.9932.4437.8
Accounts Receivable, Long Term----0.00.0
Loans Receivable, Long Term468.5------
Deferred Tax Assets, Long Term--13.758.663.7
Deferred Charges, Long Term5,453.94,152.03,435.22,731.8
Other Intangibles3,853.93,587.32,984.02,331.5
Other Long-Term Assets1,110.62,664.73,404.04,894.7
TOTAL ASSETS140,388.1147,125.4160,139.9180,616.8
Accounts Payable4,454.35,754.45,741.83,206.5
Accrued Expenses7,459.16,410.47,443.28,781.5
Short-Term Borrowings6,200.03,000.03,000.03,000.0
Current Income Taxes Payable548.3558.52,124.84,806.1
Other Current Liabilities, Total7,060.37,958.16,783.911,718.9
TOTAL CURRENT LIABILITIES25,721.923,681.325,093.731,513.0
Minority Interest181.7529.9740.3609.1
Pension & Other Post-Retirement Benefits8,145.67,277.69,020.113,558.2
Deferred Tax Liability Non-Current2,603.93,241.72,774.71,034.3
Other Non-Current Liabilities0.
TOTAL LIABILITIES36,471.434,200.636,888.446,105.5
Common Stock6,454.87,092.77,794.48,180.3
Additional Paid in Capital12,366.012,356.511,641.911,251.0
Retained Earnings85,855.093,407.5103,693.1114,988.5
Treasury Stock-572.8-574.1-579.3-589.3
Comprehensive Income and Other-368.2112.2-39.071.8
TOTAL COMMON EQUITY103,734.9112,394.9122,511.2133,902.2
TOTAL EQUITY103,916.6112,924.9123,251.5134,511.3
TOTAL LIABILITIES AND EQUITY140,388.1147,125.4160,139.9180,616.8

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003220:KS 19,400.00 KRW +600.00

003220 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003220.
View Industry Companies

Industry Analysis


Industry Average

Valuation 003220 Industry Range
Price/Earnings 21.2x
Price/Sales 1.8x
Price/Book 2.5x
Price/Cash Flow 20.1x
TEV/Sales 1.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEWON PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at